Flexibility for clinicians in managing RAS inhibitors in noncardiac surgery
Editor's Note A new study, the Stop-or-Not Trial, has found no significant difference in outcomes for patients undergoing noncardiac surgery who either continued or discontinued their renin-angiotensin system (RAS) inhibitor therapy, MedPage Today August 31 reports. The randomized clinical trial, which included over 2,200 patients, reported the rate of death…
Study: Women face higher mortality risk than men for postop atrial fibrillation after cardiac surgery
Editor's Note A recent study from two tertiary care centers highlighted significant sex differences in long-term outcomes after cardiac surgery, especially concerning postoperative atrial fibrillation (postopAF), MedPage August 21 reports. The study, published in JAMA Network, found that while women were less likely than men to develop postopAF following a…
Brain implant leverages AI, neural sensors to restore speech for ALS patient
Editor's Note Researchers at UC Davis have developed a brain-computer interface (BCI) implant that has successfully restored speech in a patient with amyotrophic lateral sclerosis (ALS), whose ability to speak had deteriorated, Fierce Biotech reported August 15. The breakthrough was achieved using neural sensors from Blackrock Neurotech and AI-driven text-to-speech…
Study: Nearly 10% of patients on prescription opioids develop dependency or disorder
Editor's Note Research reveals nearly 10% of patients treated with prescription opioid painkillers develop opioid dependency or opioid use disorder (OUD), Healio reported on August 13. Additionally, nearly 30% of patients exhibit signs and symptoms indicating potential OUD. Originally published in the journal Addiction, the data are from a systematic…
Large analysis contradicts findings on surgeon gender, patient outcomes
Editor's Note Contradicting previous research suggesting potentially improved surgical outcomes for female surgeons, the largest analysis to date finds that gender has only a small statistical, clinically marginal correlation. Appearing in the September issue of Annals of Surgery, the study involved 4,882,784 patients operated on by 11,955 female surgeons (33%…
Handheld, powered surgical tools combine advantages of traditional laparoscopy, robotics
Editor's Note Combining dexterity and cost-effectiveness, handheld robotic devices offer potential to bridge the gap between traditional laparoscopy and more expensive robotic platforms, researchers concluded August 8 in the journal Surgery. The mini-review of clinical trials covered clinical applications of three handheld robotic devices: the HandX powered laparoscopic instrument from…
Studies highlight success strategies for combatting handoff communication failure, care inequity
Editor's Note Recent research sheds new light on addressing two of the most pressing problems for surgical care: handoff communication failures and care bias and inequities leading to adverse—and preventable—events. These problems are the subjects of two separate success stories in the August issue of The Joint Commission Journal…
Study links patient mortality to low nurse staffing, overreliance on temporary hospital staff
Editor's Note A recent study conducted across 185 hospital wards in England highlights the significant impact of nurse staffing levels and staff composition on patient mortality. Published August 19 in JAMA, the study analyzed data from over 626,000 hospital admissions between 2015 and 2020. It found that low staffing levels…
Antibiotics gaining acceptance as potential alternative to pediatric appendectomy
Editor's Note Evidence is mounting for the use of antibiotics as a valid alternative to surgery for acute appendicitis, including in pediatric cases, the Washington Post reported August 17. The article details how this treatment—described as a “dark secret” by one expert testifying to its use in the 1950s, prior…
Study: Starting adjuvant chemotherapy more than 6 weeks after surgery worsens colorectal cancer survival
Editor's Note A post hoc analysis of the SCOT phase 3 randomized clinical trial reveals that initiating adjuvant chemotherapy more than 6 weeks after surgery is linked to worse disease-free survival (DFS) in patients with high-risk stage II and stage III colorectal cancer. Published June 12 in JAMA Surgery, the…
Free Daily News
- AAMI, CTA partners to develop healthcare AI standards
- ECRI issues guidance to address medical supply shortages caused by Hurricane Helene, dockworkers’ strike
- FDA designates Class 1 recall for IPV therapy system
- Study: Early detection of atherosclerosis linked to lower mortality risk
- Repeal of CON laws for ASCs expands healthcare access, number of facilities in rural areas
- Spatial computing trial shows promise for enhancing OR efficiency, reducing strain on surgeons
- Vice presidential debate highlights healthcare, abortion policy differences
- FDA designates Class 1 recalls for infusion pump software, ventilator software
- Health systems face declining margins, cut leadership amid rising costs
- Hurricane disrupts IV fluid manufacturing as hospitals cope with chaos